Singapore: A team of scientists from Japan have created a functioning human liver from stem cells, raising hopes of manu...
Singapore: Nobelpharma and Eisai launched Gliadel 7.7 mg Implant (carmustine), an antineoplastic agent, in Japan on Janu...
Singapore: Takeda Pharmaceutical has submitted a new drug application (NDA) to the Ministry of Health, Labor and Welfare...
Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...
Singapore: Sysmex Corporation and Siemens Healthcare Diagnostics have announced the signing of a five-year global supply...
Singapore: Sucampo (an affiliate of Sucampo Pharmaceuticals), R-Tech Ueno, Takeda Pharmaceutical, and certain affiliate...
Japan's Chugai Pharmaceutical, which pursues cutting-edge biopharmaceutical, antibody, and molecular targeted research t...
Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...
Singapore: Japan's health ministry has lodged a criminal complaint against the local wing of the leading Swiss drug make...
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...
Singapore: Mylan Specialty, a subsidiary of Mylan, and Pfizer entered into a license agreement, under which Pfizer will ...
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...
Singapore: Stroke, the destruction of brain tissue from blockage or rupture of blood vessels, is one of the leading caus...
Singapore: Japanese pharmaceutical company Eisai has said that it will soon begin therapeutic testing of a drug that it ...
